Cas no 1225022-67-2 (gentiside B)
gentiside B Chemical and Physical Properties
Names and Identifiers
-
- gentiside B
- CHEMBL592173
- 1225022-67-2
- AKOS040761777
- CS-0158690
- HY-N9096
- [(20S)-20-methyldocosyl] 2,3-dihydroxybenzoate
- ((20S)-20-methyldocosyl) 2,3-dihydroxybenzoate
-
- Inchi: 1S/C30H52O4/c1-3-26(2)22-19-17-15-13-11-9-7-5-4-6-8-10-12-14-16-18-20-25-34-30(33)27-23-21-24-28(31)29(27)32/h21,23-24,26,31-32H,3-20,22,25H2,1-2H3/t26-/m0/s1
- InChI Key: FIEXPCXAWNKDMT-SANMLTNESA-N
- SMILES: O(C(C1C=CC=C(C=1O)O)=O)CCCCCCCCCCCCCCCCCCC[C@@H](C)CC
Computed Properties
- Exact Mass: 476.38656014g/mol
- Monoisotopic Mass: 476.38656014g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 34
- Rotatable Bond Count: 23
- Complexity: 467
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 1
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 12.9
- Topological Polar Surface Area: 66.8?2
Experimental Properties
- Color/Form: Powder
- Density: 1.0±0.1 g/cm3
- Boiling Point: 570.4±30.0 °C at 760 mmHg
- Flash Point: 170.9±18.1 °C
- Vapor Pressure: 0.0±1.6 mmHg at 25°C
gentiside B Security Information
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:Store at 4 ℃, better at -4 ℃
gentiside B Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | G26360-5 mg |
gentiside B |
1225022-67-2 | 5mg |
¥5120.0 | 2021-09-09 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN4126-1 mg |
Gentiside B |
1225022-67-2 | 1mg |
¥2595.00 | 2022-04-26 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | G26360-5mg |
gentiside B |
1225022-67-2 | ,97.5% | 5mg |
¥5120.0 | 2023-09-07 | |
| TargetMol Chemicals | TN4126-5mg |
Gentiside B |
1225022-67-2 | 5mg |
¥ 3560 | 2024-07-20 | ||
| TargetMol Chemicals | TN4126-5 mg |
Gentiside B |
1225022-67-2 | 98% | 5mg |
¥ 3,560 | 2023-07-11 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN4126-1 mL * 10 mM (in DMSO) |
Gentiside B |
1225022-67-2 | 1 mL * 10 mM (in DMSO) |
¥ 3660 | 2023-09-07 | ||
| TargetMol Chemicals | TN4126-1 ml * 10 mm |
Gentiside B |
1225022-67-2 | 1 ml * 10 mm |
¥ 3660 | 2024-07-20 |
gentiside B Related Literature
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
-
Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
-
Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
-
Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
-
Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
Additional information on gentiside B
Introduction to Gentiside B (CAS No. 1225022-67-2)
Gentiside B, also known as gentiside B, is a naturally occurring compound that has garnered significant attention in recent years due to its unique chemical properties and potential biological activities. This compound, identified by the CAS number 1225022-67-2, belongs to the class of flavonoids, a group of plant-derived secondary metabolites known for their diverse roles in human health and disease prevention. Gentiside B is particularly notable for its structural complexity and its ability to interact with various cellular pathways, making it a subject of extensive research in the fields of pharmacology, nutrition, and biotechnology.
The discovery of Gentiside B was initially reported in studies focusing on the bioactive compounds present in certain medicinal plants. Recent advancements in analytical chemistry have allowed researchers to isolate and characterize this compound with unprecedented precision. Its molecular structure, which includes a flavone skeleton with specific substituents, contributes to its unique pharmacokinetic properties. These properties include high bioavailability and the ability to penetrate cellular membranes, which are critical factors for its potential therapeutic applications.
One of the most promising areas of research involving Gentiside B is its role in antioxidant activity. Studies have demonstrated that Gentiside B exhibits potent free radical scavenging capabilities, which are essential for protecting cells from oxidative stress—a process implicated in numerous chronic diseases, including cardiovascular disorders and neurodegenerative conditions. Moreover, Gentiside B has been shown to modulate key enzymes involved in inflammation, suggesting its potential as an anti-inflammatory agent.
In addition to its antioxidant and anti-inflammatory properties, Gentiside B has also been investigated for its effects on cellular signaling pathways. For instance, research indicates that Gentiside B can influence the activity of nuclear factor-kappa B (NF-κB), a transcription factor that plays a central role in immune responses and inflammation. This modulation could have significant implications for the development of novel therapies targeting inflammatory diseases such as arthritis and inflammatory bowel disease.
Another area of interest is the potential of Gentiside B in cancer prevention and treatment. Preclinical studies have shown that Gentiside B can induce apoptosis in cancer cells while sparing healthy cells, indicating its selective cytotoxicity. Furthermore, it has been found to inhibit the proliferation of cancer cells by interfering with key signaling pathways such as the PI3K/AKT/mTOR pathway. These findings suggest that Gentiside B could serve as a lead compound for the development of anticancer drugs.
The application of Gentiside B extends beyond pharmacology into the realm of food science and nutrition. Due to its strong antioxidant properties, Gentiside B is being explored as a natural food additive to enhance the shelf life of food products while maintaining their nutritional quality. Additionally, it has potential applications in cosmetic formulations aimed at protecting the skin from environmental stressors such as UV radiation.
Recent advancements in biotechnology have also opened new avenues for the production of Gentiside B. Traditionally obtained from plant sources, Gentiside B can now be synthesized through metabolic engineering techniques, which offer greater control over its production process and scalability. This development is expected to facilitate large-scale production of Gentiside B for both therapeutic and industrial applications.
In conclusion, Gentiside B (CAS No. 1225022-67-2) represents a compelling example of how natural compounds can be harnessed for diverse applications across multiple industries. With ongoing research uncovering new insights into its biological mechanisms and therapeutic potentials, Gentiside B stands at the forefront of innovative solutions in medicine, nutrition, and beyond.
1225022-67-2 (gentiside B) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)